A number of deregulated genes with activating mutations or translocations for T-ALL are described in the literature: CDKN2A (61%), CDKN2B (58%), NOTCH1 (50%), TAL1 (30%), and FBXW7 (14%) [14]. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.